| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/14/2006 | CN1259417C Coding sequence of arisaema agglutinant protein and its application |
| 06/14/2006 | CN1259340C Peptide composition as immunogen for treatment of allergy |
| 06/14/2006 | CN1259339C Genetically engineering monoclonal anti-digoxin single-stranded antibody and its use |
| 06/13/2006 | US7060868 Autoimmune disease model animal |
| 06/13/2006 | US7060847 Ecstasy-class derivatives, immunogens, and antibodies and their use in detecting ecstasy-class drugs |
| 06/13/2006 | US7060808 Epidermal growth factor; nucleic acids, protein which binds to epidermal growth factor receptors; genetic engineering |
| 06/13/2006 | US7060805 Methods for isolating tissue factor inhibitor |
| 06/13/2006 | US7060804 Method for isolating proteins or protein and nucleic acid associations, or particle and protein complexes, reagent and uses |
| 06/13/2006 | US7060802 Monoclonal antibody hybridomas ; detecting cancer |
| 06/13/2006 | US7060801 Antibodies to human growth factor huXAG-3 and methods of use |
| 06/13/2006 | US7060800 Polypeptides for use in the treatment and diagnosis of crohn's disease |
| 06/13/2006 | US7060799 Detecting preferential antibody in sample; obtain sample which contains preferential epitopes, incubate with antibodies, detect signal |
| 06/13/2006 | US7060796 Antibody directed against purified β 1,2-xylosyltransferase |
| 06/13/2006 | US7060790 Genetic engineering; antitumor agents; therapy for microbiocide infections; antiinflammatory agents; immunology |
| 06/13/2006 | US7060688 A gene therapy for cancers, comprising a cancer suppressing gene; genetic engineering, duplicated gene, cloned gene |
| 06/13/2006 | US7060682 direct interaction with the ligand-bound receptor and activation of one or more transcription factors; unaffected by the presence or concentration of second messengers; direct interaction with tyrosine kinase domains; absence of interaction with G-proteins; transcriptional stimulation of target genes |
| 06/13/2006 | US7060680 Compositions for maintaining the integrity of the gastrointestinal tract luminal lining in a mammal, including (1) limiting epithelial cell proliferation, (2) inhibiting ulcerative lesion formation, (3) inhibiting inflammation |
| 06/13/2006 | US7060676 Administering a therapeutically effective amount Trypanosoma cruzi trans-sialidase or a neurotrophic variant; amyotrophic lateral sclerosis, Alzheimer's disease, Parkinson's disease, Huntington's disease, Chagas' disease, peripheral neuropathy, |
| 06/13/2006 | US7060670 having a sequence identified from the glycosaminoglycan (GAG) binding region and the prot prot interaction region of the amylo protein and having at least one amino acid isomer substitution; for inhibiting amyloidosis and/or for cytoprotection |
| 06/13/2006 | US7060504 High mobility group proteins; diagnostic monitoring the severity or potential lethality of sepsis or septic shock, measuring the serum protein concentration of patient, treating weight loss or obesity |
| 06/13/2006 | US7060495 Polypeptide for use in as anticarcinogenic agent |
| 06/13/2006 | US7060481 Comprises peptide for diagnosing and treating inflammatory, tumor, arthritic and nervous system disorders |
| 06/13/2006 | US7060456 Regulation of human protein phosphatase IIc-like enzyme |
| 06/13/2006 | US7060449 Method of preparing GALR2 receptors composition |
| 06/13/2006 | US7060448 Evaluating binding affinities by force stratification and force panning |
| 06/13/2006 | US7060284 Polypeptides and polynucleotides for enhancing immune reactivity to HER-2 protein |
| 06/13/2006 | US7060273 Methods for inhibiting HIV-1 infection |
| 06/13/2006 | US7060272 Death domain containing receptor-4 agonist antibodies and methods |
| 06/13/2006 | US7060271 Specifically bind to the extracellular domain of the human type beta PDGF receptor; diagnostic and therapeutic uses |
| 06/13/2006 | US7060270 Brain disorders; Alzheimer's disease; Down syndrome; hybridomas cell line; medical diagnosis |
| 06/13/2006 | US7060269 Anti-VEGF antibodies |
| 06/13/2006 | US7060268 Stability; freeze drying; regeneration |
| 06/13/2006 | US7060267 MASP-2, a complement-fixing enzyme, and uses for it |
| 06/13/2006 | CA2407760C Methods for diagnosis of low grade astrocytoma |
| 06/13/2006 | CA1341508C Transforming growth factor peptides |
| 06/08/2006 | WO2006060643A2 Novel bladder matrix protein peptides and methods of detection of bladder cancer |
| 06/08/2006 | WO2006060513A2 Toll like receptor 3 antagonists, methods and uses |
| 06/08/2006 | WO2006060419A2 Biomarkers for pre-selection of patients for anti-igf1r therapy |
| 06/08/2006 | WO2006060083A1 Methods for refolding polypeptides |
| 06/08/2006 | WO2006060021A2 Bifunctional fusion proteins containing the flt3 ligand |
| 06/08/2006 | WO2006060020A1 Sm5-1 antibodies and applications thereof |
| 06/08/2006 | WO2006059914A1 Modulation of ovulation |
| 06/08/2006 | WO2006059913A1 Modulation of ovulation |
| 06/08/2006 | WO2006059904A1 Method for affinity purification |
| 06/08/2006 | WO2006059712A1 Monoclonal antibody binding to human steroid sulfatase |
| 06/08/2006 | WO2006059176A1 Naturally occuring igm antibodies that bind lymphocytes |
| 06/08/2006 | WO2006058890A2 Method of producing antibodies |
| 06/08/2006 | WO2006031994A3 Monomeric immunoglobulin fc domains |
| 06/08/2006 | WO2006014683A3 Immunoglobulins comprising predominantly a gal2glcnac2man3glcnac2 glycoform |
| 06/08/2006 | WO2006013474A3 PPGALNAC-t6 MRNA or peptide as a new marker for detection cancer cells |
| 06/08/2006 | WO2006012508A3 Method of treating sjögren's syndrome |
| 06/08/2006 | WO2006004620A3 Enterotoxin gene cluster (egc) superantigens to treat malignant disease |
| 06/08/2006 | WO2005117968A3 Compositions and methods comprising an egfl7 antagonist for modulating vascular development |
| 06/08/2006 | WO2005113600A3 Methods for the control, treatment and management of obesity |
| 06/08/2006 | WO2005111079A3 Hiv vaccine immunogens and immunization strategies to elicit broadly-neutralizing anti-hiv-1 antibodies against the membrane proximal domain of hiv gp41 |
| 06/08/2006 | WO2005092926A3 Reducing the risk of human and anti-human antibodies through v gene manipulation |
| 06/08/2006 | WO2005090393A3 Multimeric protein toxins to target cells having multiple identifying characteristics |
| 06/08/2006 | WO2005089043A3 Prostate stem cell |
| 06/08/2006 | WO2005072385A3 Pituitary adenylate cyclase activating peptide (pacap) receptor (vpac2) agonists and their pharmacological methods of use |
| 06/08/2006 | WO2005002527A3 Sirt1 modulation of adipogenesis and adipose function |
| 06/08/2006 | WO2004073653A3 Methods for treating pain by administering a nerve growth factor antagonist and an nsaid and compositions containing the same |
| 06/08/2006 | WO2004042005A3 Methods of preparing improved agents by coevolution |
| 06/08/2006 | WO2003076571A3 Cancer-linked gene as target for chemotherapy |
| 06/08/2006 | US20060123505 Full-length plant cDNA and uses thereof |
| 06/08/2006 | US20060123495 Knockout mice and their use |
| 06/08/2006 | US20060122377 CDR-repaired antibodies |
| 06/08/2006 | US20060122372 Polymorphisms in the human genes for oct1 and their use in diagnostic and therapeutic applications |
| 06/08/2006 | US20060122370 Specific binding agents of human angiopoietin-2 |
| 06/08/2006 | US20060122368 Antigen delivery platform |
| 06/08/2006 | US20060122259 Immobilization of taxane; anticancer, antitumor agents |
| 06/08/2006 | US20060122117 Method of treating retinopathies and disorders associated with blood vessel loss |
| 06/08/2006 | US20060121591 Mutant proteinase-inhibitors and uses thereof |
| 06/08/2006 | US20060121574 Recombinant method for making multimeric proteins |
| 06/08/2006 | US20060121570 Methods for producing polypeptide binding sites, monoclonal antibodies and compositions thereof |
| 06/08/2006 | US20060121563 Novel tricistronic vectors and uses therefor |
| 06/08/2006 | US20060121545 Rapamycin conjugates and antibodies |
| 06/08/2006 | US20060121539 Eph receptor tumor biomarkers |
| 06/08/2006 | US20060121536 Novel uses of antibodies against AChE and peptides thereof |
| 06/08/2006 | US20060121529 CpG receptor (CpG-R) and methods relating thereto |
| 06/08/2006 | US20060121527 Oncoprotein protein kinase |
| 06/08/2006 | US20060121514 Prostacyclin-stimulating Factor-2 |
| 06/08/2006 | US20060121508 Alternatively spliced isoforms of purinergic receptor P2X, ligand-gated ion channel, subunits 3 and 4 (P2RX3, P2RX4) |
| 06/08/2006 | US20060121505 Beta chain-associated regulator of apoptosis |
| 06/08/2006 | US20060121484 From mouse bone marrow; immunoglobulins; vectors, host cells; allergies |
| 06/08/2006 | US20060121480 Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome |
| 06/08/2006 | US20060121471 Gene families associated with stomach cancer |
| 06/08/2006 | US20060121465 Sgk and nedd used as diagnostic and therapeutic targets |
| 06/08/2006 | US20060121460 Toll-like receptor 11 |
| 06/08/2006 | US20060121459 Receptors and membrane-associated proteins |
| 06/08/2006 | US20060121456 Isolated human ras-like proteins acid molecules encoding these human ras-like proteins, and uses thereof |
| 06/08/2006 | US20060121454 diagnosis and treatment of carcinomas, especially breast cancers |
| 06/08/2006 | US20060121042 Modulation of antibody specificity by tailoring the affinity to cognate antigens |
| 06/08/2006 | US20060121038 treating Alzheimer's disease by administering a humanized or chimeric antibody that specifically binds to an epitope within A beta 3-6 and monitoring the response |
| 06/08/2006 | US20060121037 Anti-TNF antibodies and peptides of human tumor necrosis factor |
| 06/08/2006 | US20060121035 Methods for treating diabetes |
| 06/08/2006 | US20060121033 Using antibodies which bind specifically to DC-SIGN; Agents that bind to ICAM-3 are used to block inhibition of activation of macrophages by DC-SIGN-ICAM-3 interaction and cause inhibition of rheumatoid arthritis symptoms |
| 06/08/2006 | US20060121031 Relay vaccine |
| 06/08/2006 | US20060121030 Use of cd 137 antagonists for the treatment of tumors |
| 06/08/2006 | US20060121028 Variant IgG3 RITUXAN and therapeutic uses thereof |
| 06/08/2006 | US20060121026 Immunoglobulins devoid of light chains |